Geoff Rickly Gives Update On Collect Records

Back in September, The New York Times published an article about Turig Pharmaceuticals raising the price of the drug Deraprim by 5000 percent per tablet and the nefarious price-gouging chief executive behind that decision, Martin Shkreli. Deraprim is typically used to treat infections in people with compromised immune systems, like cancer patients and those who […]

Read full article Share article